Anlai Wang

2.3k citations

40 papers · 958 indexed · h-index 12

Impact in

Hematology top 5%
- Hematopoietic Stem Cell Transplantation
- Platelet Disorders and Treatments
- Multiple Myeloma Research and Treatments
Immunology top 10%
- Immune Response and Inflammation
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses

Papers in

Physiology 3
Organic Chemistry 18
- Cyclization and Aryne Chemistry 9
- Synthesis and pharmacology of benzodiazepine derivatives 6
- Synthesis and Reactivity of Heterocycles 3

Co-authors: David T. Scadden Peter Lopez Anna C. Berardi James D. Levine Marion Dorsch Chafen Lu Yajun Xu Timothy D. Ocain
Journals: Tetrahedron (3 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Biochemical and Biophysical Research Communications (3 papers)Cancer Research (3 papers)Journal of the Chemical Society Perkin Transactions 1 (2 papers)
Partner nations: United States France China

In The Last Decade

Anlai Wang

39 papers receiving 927 citations

Peers

Countries citing papers authored by Anlai Wang

Since Specialization

Citations

This map shows the geographic impact of Anlai Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anlai Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anlai Wang more than expected).

Fields of papers citing papers by Anlai Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anlai Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anlai Wang. The network helps show where Anlai Wang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Anlai Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anlai Wang Line = papers co-authored together Anlai Wang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Discovery of Pyrazolopyridine Derivatives as HPK1 Inhibitors ACS Medicinal Chemistry Letters ·Wendy Guzenski, Marlene Welker, Протопопов Алексей Владимирович, Amir Nasrelddine, Rehna M. Ahmed, Anlai Wang, Ke Zhang, Joshua R. Hummel, Ling Kong, Elham Behshad, Xin He, Andrew C. Bates, Simantini Sushant Jadhav, Min Ye, Sharon Diamond, Maryanne Covington, Swamy Yeleswaram, Onur Atasoylu, ALIYEV R.T., Wenqing Yao	2022	8
2	Evaluation of Preclinical Activity of Isatuximab in Patients with Acute Lymphoblastic Leukemia Molecular Cancer Therapeutics ·Anlai Wang, Zhili Song, Gang Zheng, Céline Nicolazzi, Jonathan R. Fromm, Keeratipron Yoaharee, Srimathi Srinivasan, Xueyan Chen, Chen Zhu, Rafia Basit, Francisco Adrián	2021	11
3	Prediction and Allocation of EDP Based on Gray Model and Fuzzy Comprehensive Evaluation Mathematical Problems in Engineering ·周克胜, Anlai Wang, Lalit M Kandpal, M.K. Koleva, Xusheng Kang	2021	3
4	Discovery of SARxxxx92, a pan-PIM kinase inhibitor, efficacious in a KG1 tumor model Bioorganic & Medicinal Chemistry Letters ·Claude Barberis, Paul Erdman, معصومه زری بافان, Haipo Yuan, MAGON D.P.S., Строкан Павел Владимирович, Junqing Feng, Joseph D. Batchelor, Jinyu Liu, Vinod F. Patel, Andrew Hebert, Mikhail Levit, Anlai Wang, Frank F. Sun, Shih-Min A. Huang	2020	7
5	Isatuximab Acts Through Fc-Dependent, Independent, and Direct Pathways to Kill Multiple Myeloma Cells Frontiers in Immunology ·Chen Zhu, Zhili Song, Anlai Wang, Srimathi Srinivasan, Guang Yang, Rita Greco, Joachim Theilhaber, Keeratipron Yoaharee, Lan Wu, Zhiyong Yang, 勝助小松, Alain Fournier, Yu‐Tzu Tai, Kenneth C. Anderson, Dmitri Wiederschain, Keith S. Bahjat, Francisco Adrián, Marielle Chiron	2020	85
6	Discovery of N-substituted 7-azaindoles as Pan-PIM kinases inhibitors – Lead optimization – Part III Bioorganic & Medicinal Chemistry Letters ·Claude Barberis, MAGON D.P.S., Строкан Павел Владимирович, K. Laker, معصومه زری بافان, Xiaoming Liu, Paul Erdman, Junqing Feng, John Jiang, Haipo Yuan, Vinod F. Patel, Andrew Hebert, Mikhail Levit, Anlai Wang, Frank F. Sun, Shih-Min A. Huang	2018	7
7	Discovery of N-substituted 7-azaindoles as Pan-PIM kinase inhibitors – Lead series identification – Part II Bioorganic & Medicinal Chemistry Letters ·Claude Barberis, Ewan Murray‐Will, MAGON D.P.S., Строкан Павел Владимирович, K. Laker, معصومه زری بافان, Xiaoming Liu, Paul Erdman, Tahir Majid, Joseph D. Batchelor, Mikhail Levit, Andrew Hebert, C. Johnston, ALESSANDRA GENU DUTRA AMARAL, Anlai Wang	2017	5
8	Combination of PIM and JAK2 inhibitors synergistically suppresses cell proliferation and overcomes drug resistance of myeloproliferative neoplasms Oncotarget ·B. Bondars, Anlai Wang, Rita Greco, Zhifang Li, Fangxian Sun, Claude Barberis, Michel Tabart, Vinod F. Patel, Laurent Schio, Н. Г. Пшук, Bo Zhi Chen, Hong Cheng, Christoph Lengauer, Jack Pollard, James J. Watters, Fati Yıldırım, Dmitri Wiederschain, Francisco Adrián, 藤丸忠夫	2014	24
9	Pharmacological characterization of INCB3344, a small molecule antagonist of human CCR2 Biochemical and Biophysical Research Communications ·Niu Shin, Frédéric Baribaud, Kathy Wang, Genjie Yang, 林源根, Maryanne Covington, Patricia Feldman, Karen Gallagher, Lynn Leffet, Yvonne Lo, Anlai Wang, Chu‐Biao Xue, Robert Newton, Peggy Scherle	2009	21
10	Regulation of IRAK-4 kinase activity via autophosphorylation within its activation loop Biochemical and Biophysical Research Communications ·Hong Cheng, Terri A. Addona, Hasmik Keshishian, Nedret Kuran Burçoğlu, Chafen Lu, Marion Dorsch, Zhi Li, Anlai Wang, Timothy D. Ocain, Ping Li, Thomas F. Parsons, Bruce Jaffee, Yajun Xu	2006	61
11	Identification of a regulatory autophosphorylation site in the serine–threonine kinase RIP2 Cellular Signalling ·Marion Dorsch, Anlai Wang, Hong Cheng, Chafen Lu, S. Sugiyama, Paul Byford, Karl R. Clauser, Christina Kleiber, Roberto D. Polakiewicz, Tom Parsons, Ping Li, Kerstin Tillmanns, Yajun Xu	2006	53
12	Nucleotide binding to CARD12 and its role in CARD12-mediated caspase-1 activation Biochemical and Biophysical Research Communications ·Chafen Lu, Anlai Wang, Lin Wang, Marion Dorsch, Timothy D. Ocain, Yajun Xu	2005	31
13	Participation of Rip2 in Lipopolysaccharide Signaling Is Independent of Its Kinase Activity Journal of Biological Chemistry ·Chafen Lu, Anlai Wang, Marion Dorsch, Jane Tian, Kumiko Nagashima, Anthony J. Coyle, Bruce Jaffee, Timothy D. Ocain, Yajun Xu	2005	62
14	Facile one-pot synthesis of 10-aryl derivatives of 9-aminoanthracenes and 9,10-dihydroanthracen-9-imines ARKIVOC ·Anlai Wang, Hongming Zhang, Adriano Efraín Pérez Toapanta, Aimee S. Maravi, J Tolk, Edward R. Biehl	2001	1
15	The Preparation of Certain Nitrogen and Sulfur Containing Polycyclic Heterocycles by the Reaction of Arynes Possessing Charged Groups with a-Lithio-a-cyano-o-tolunitrile and a-Lithio-3-thienylacetonitrile Heterocycles ·Edward R. Biehl, Anlai Wang, Hongming Zhang	2000	3
16	Preparation of N 1-Alkyl- and N 1,N 1-Di- alkylisoquinoline-1,3-diamines and 1- Alkyl- and 1-Phenylisoquinolin-3-amines from the Reaction of a-Cyano-o-tolunitrile with Lithium Amides, Alkyllithiums, and Phenyllithium Heterocycles ·Edward R. Biehl, Anlai Wang, Hongming Zhang	2000	6
17	A Human Anti-HIV Autoantibody Enhances EBV Transformation and HIV Infection Clinical Immunology ·Lisa A. Cavacini, Adam V. Wisnewski, Yuan-Yan An, David C. Montefiori, Lucía Bordello Malde, Mark Duval, Gillian A. Kingsbury, Anlai Wang, David T. Scadden, Marshall R. Posner	1999	9
18	Crystal and molecular structure of 1,6:3,4-dianhydro-2-O-p-tolylsulfonyl-β-d-galactopyranose Carbohydrate Research ·Anlai Wang, Shijie Lu, Hongxiang Fu, Hanqing Wang, Xiao‐Ying Huang	1996	6
19	Functional Isolation and Characterization of Human Hematopoietic Stem Cells Science ·Anna C. Berardi, Anlai Wang, James D. Levine, Peter Lopez, David T. Scadden	1995	346
20	In vitro effects of stem-cell factor or interleukin-3 on myelosuppression associated with AIDS AIDS ·David T. Scadden, Anlai Wang, Krisztina M. Zsebo, Jerome E. Groopman	1994	11

About Anlai Wang

Anlai Wang is a scholar working on Physiology, Organic Chemistry, Physical and Theoretical Chemistry, Hematology and Immunology, having authored 40 papers that have together received 958 indexed citations. Recurring topics across this work include Cyclization and Aryne Chemistry (9 papers), Immune Cell Function and Interaction (7 papers), Synthesis and pharmacology of benzodiazepine derivatives (6 papers), Cancer Mechanisms and Therapy (5 papers), Chemical Reactions and Mechanisms (5 papers), Synthesis and Reactivity of Heterocycles (3 papers), Peptidase Inhibition and Analysis (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Hematology (312 citations), Immunology (356 citations), Genetics (103 citations), Oncology (228 citations) and Physiology (27 citations). Anlai Wang has collaborated with scholars based in United States, France and China. Frequent co-authors include David T. Scadden, Peter Lopez, Anna C. Berardi, James D. Levine, Marion Dorsch, Chafen Lu, Yajun Xu, Timothy D. Ocain, Shijie Lu and Bruce Jaffee. Their work appears in journals such as Tetrahedron, Bioorganic & Medicinal Chemistry Letters, Biochemical and Biophysical Research Communications, Cancer Research and Journal of the Chemical Society Perkin Transactions 1.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact